Residue of Chlormequat and Regulatory Effects on the Specialized Metabolites of Astragali Radix

Author:

Qin Honghan1,Xie Lei2,Zang Yimei23,Han Jia3,Yu Jing4,Luo Zuliang2ORCID,Ma Xiaojun2ORCID

Affiliation:

1. College of Pharmacy, Youjiang Medical University for Nationalities, Baise 533000, China

2. Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China

3. Biomedicine College, Beijing City University, Beijing 100094, China

4. Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong 666100, China

Abstract

Presently, the utilization of chlormequat in Astragalus mongholicus Bunge (Leguminosae) cultivation is prevalent for augmenting rhizome (Astragali Radix) yield. However, indiscriminate and excessive chlormequat employment can detrimentally influence Astragali Radix quality and safety. This research aimed to comprehensively comprehend chlormequat risks and its influence on Astragali Radix metabolites. Diverse chlormequat concentrations were employed in Astragalus mongholicus cultivation, with subsequent analysis of residual chlormequat levels in Astragali Radix across treatment groups. Astragali Radix metabolic profiling was conducted through UPLC-QTOF-MS, and thirteen principal active components were quantified via UFLC-MS/MS. Findings revealed a direct correlation between chlormequat residue levels in Astragali Radix and application concentration, with high-dose residue surpassing 5.0 mg/kg. Metabolomics analysis identified twenty-six distinct saponin and flavonoid metabolites. Notably, the application of chlormequat led to the upregulation of seven saponins (e.g., astragaloside I and II) and downregulation of six flavonoids (e.g., methylnissolin-3-O-glucoside and astraisoflavan-7-O-β-d-glucoside). Quantitative analysis demonstrated variable contents of active ingredients due to differing chlormequat concentrations, leading to astragaloside I increase (14.59–62.55%) and isoastragaloside II increase (4.8–55.63%), while methylnissolin-3-O-glucoside decreased (22.18–41.69%), as did astraisoflavan-7-O-β-d-glucoside (21.09–47.78%). In conclusion, chlormequat application influenced multiple active components in Astragali Radix, causing constituent proportion variations. Elevated chlormequat concentrations led to increased active components alongside heightened chlormequat residues in Astragali Radix. Consequently, prudent chlormequat application during Astragali Radix production is imperative to avert potential detriments to its quality and safety.

Funder

CAMS Innovation Fund for Medical Sciences

the National Natural Science Foundation of China

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Reference44 articles.

1. Chinese Pharmacopoeia Commission (2020). Pharmacopoeia of People’s Republic of China, Chemical Medical Science Press.

2. Astragali Radix (Huangqi): A promising edible immunomodulatory herbal medicine;Chen;J. Ethnopharmacol.,2020

3. Astragalus, an ancient medicinal root in traditional Chinese medicine, a gift from silk road;Shahrajabian;Int. J. Agric. Biol. Sci.,2019

4. Gong, A.G., Duan, R., Wang, H.Y., Kong, X.P., Dong, T.T., Tsim, K.W., and Chan, K. (2018). Evaluation of the pharmaceutical properties and value of Astragali Radix. Medicines, 5.

5. A review of Astragalus species as foodstuffs, dietary supplements, a traditional Chinese medicine and a part of modern pharmaceutical science;Shahrajabian;Appl. Ecol. Environ. Res.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3